Guidewires and Introducer Sheaths Market: Rising Prevalence of Cardiovascular Diseases to Drive Market Growth to US$ 2,981.31 Million by 2033.

As per the latest market research by Business Market Insights (BMI), the research report" Guidewires and Introducer Sheaths Market Size and Forecast (2025–2033)" forecasts how the market is set to surge 92.07% by 2033. Growth in the guidewires and introducer sheaths market is driven by the rising incidence of coronary artery disease and peripheral artery disease, leading to higher volumes of angioplasty, stenting, and vascular interventions. Increasing preference for minimally invasive, catheter-based procedures, along with technological advancements such as hydrophilic coatings, improved torque control, and low-profile designs, enhances procedural efficiency. Expanding Cath lab infrastructure, growing elderly populations, and wider adoption of radial and peripheral access techniques further accelerate demand.

The report forecasts the market to expand from US$ 1,552.24 million in 2024 to US$ 2,981.31 million by 2033, registering a robust CAGR of 7.52% over the 2025–2033 period.

The global guidewires and introducer sheaths market, focused on coronary and peripheral interventions, represents a core component of interventional cardiology and vascular procedures. These devices are essential for gaining and maintaining vascular access during angioplasty, stent placement, atherectomy, and other catheter-based treatments targeting coronary and peripheral artery disease. Market expansion is closely associated with the growing burden of atherosclerosis, diabetes, and hypertension, which increase the need for revascularization procedures. The shift toward minimally invasive techniques over open vascular surgery continues to drive adoption, supported by improvements in device performance such as enhanced flexibility, kink resistance, hydrophilic coatings, and reduced sheath profiles. Rising establishment of catheterization laboratories, increasing procedural volumes, and a steadily aging population prone to vascular disorders collectively reinforce the market’s importance in modern cardiovascular and peripheral care.

Overview of report findings

Market Growth

The guidewires and introducer sheaths market is projected to grow from US$ 1,552.24 million in 2024 to US$ 2,981.31 million by 2033, registering a compound annual growth rate (CAGR) of 7.52% between 2025 and 2033.

Growth in the guidewires and introducer sheaths market is driven by the rising incidence of coronary artery disease and peripheral artery disease, leading to higher volumes of angioplasty, stenting, and vascular interventions. Increasing preference for minimally invasive, catheter-based procedures, along with technological advancements such as hydrophilic coatings, improved torque control, and low-profile designs, enhances procedural efficiency. Expanding Cath lab infrastructure, growing elderly populations, and wider adoption of radial and peripheral access techniques further accelerate demand.

Rising Prevalence of Cardiovascular Diseases

The growing global burden of cardiovascular diseases, particularly coronary artery disease (CAD) and peripheral artery disease (PAD), is a primary driver for the guidewires and introducer sheaths market. Increasing incidence of atherosclerosis, arterial blockages, and vascular narrowing is leading to a higher number of diagnostic angiographies and interventional procedures such as coronary angioplasty, stent placement, and peripheral revascularization. These procedures rely fundamentally on guidewires for vessel navigation and introducer sheaths for secure vascular access, making them indispensable in routine clinical practice. Earlier disease detection and improved screening programs are also identifying more patients at treatable stages, further increasing procedural volumes. In addition, recurrence of vascular conditions often necessitates repeat interventions, sustaining long-term device demand. As hospitals expand catheterization laboratory capacity and interventional cardiology services, the consumption of access devices continues to rise in parallel with procedure growth. The chronic and progressive nature of cardiovascular diseases ensures a consistent patient pool requiring catheter-based treatment, positioning guidewires and introducer sheaths as essential tools in managing coronary and peripheral vascular disorders worldwide.

Aging Population & Lifestyle Factors

The steady growth of the global elderly population significantly contributes to demand for coronary and peripheral vascular interventions, driving the guidewires and introducer sheaths market. Aging is strongly associated with vascular degeneration, arterial stiffness, and plaque build-up, which increase the likelihood of coronary artery disease and peripheral artery disease. Older patients frequently require procedures such as angioplasty, stenting, and peripheral vessel revascularization, all of which depend on reliable vascular access and precise wire navigation. Alongside aging, modern lifestyle factors — including sedentary behavior, unhealthy diets, smoking, obesity, diabetes, and hypertension — are accelerating vascular disease onset even in middle-aged populations. This combination expands the overall patient base eligible for minimally invasive vascular treatments. As clinicians increasingly favor catheter-based approaches for elderly and high-risk patients due to lower procedural trauma compared to open surgery, utilization of guidewires and introducer sheaths continues to rise. The long-term management needs of chronic vascular conditions, including follow-up and repeat interventions, further reinforce sustained device demand across both coronary and peripheral care settings.

Geographic Insights

North America leads the coronary and peripheral guidewires and introducer sheaths market due to high volumes of angioplasty and peripheral vascular interventions, advanced catheterization laboratory infrastructure, and strong adoption of minimally invasive cardiovascular procedures. The region benefits from early technology uptake, favorable reimbursement systems, and a high prevalence of coronary artery disease and peripheral artery disease. Established interventional cardiology networks and continuous device innovation further strengthen procedural demand.

Europe holds the second-largest share driven by a growing elderly population and a substantial burden of coronary and peripheral vascular disorders. Well-developed public healthcare systems, expanding access to interventional cardiology services, and increasing preference for catheter-based revascularization procedures support device utilization. Technological adoption across Western Europe, alongside gradual infrastructure improvements in Eastern Europe, contributes to stable market expansion across coronary and peripheral intervention settings.

Asia Pacific represents the fastest-growing market due to rising cardiovascular disease incidence, improving healthcare infrastructure, and expanding access to coronary and peripheral interventions. Rapid urbanization, increasing diabetes and hypertension prevalence, and greater awareness of minimally invasive treatments are driving procedural volumes. Investments in new hospitals and catheterization laboratories, combined with a large aging population and growing medical tourism, accelerate demand for vascular access devices.

Market Segmentation

• By product type, the guidewires and introducer sheaths market is segmented into coronary guidewires, standard introducer sheaths, peripheral guidewires, specialty introducer sheaths, and structural heart guidewires. The coronary guidewires segment dominated the market in 2024. Coronary guidewires dominate due to their critical role in minimally invasive procedures, the rising prevalence of coronary artery disease, and technological advancements ensuring precision, safety, and improved patient outcomes in cardiovascular interventions.
• By coating, the guidewires and introducer sheaths market is segmented into coated and non-coated. The coated segment dominated the market in 2024. Coated guidewires led the market as surface coatings enhance durability, reduce friction, improve navigation through complex vessels, and minimize complications, making them the preferred choice among physicians for efficiency and patient safety.
• By application, the guidewires and introducer sheaths market is segmented into coronary artery disease, peripheral artery disease, and structural heart disease. The coronary artery disease segment dominated the market in 2024. The coronary artery disease segment dominated as increasing global incidence, lifestyle risk factors, and demand for advanced interventional cardiology solutions drove adoption of guidewires and sheaths tailored for coronary procedures.
• By end user, the guidewires and introducer sheaths market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment dominated the market in 2024. Hospitals dominated the market since they handle the majority of complex cardiovascular interventions, offer advanced infrastructure, skilled specialists, and comprehensive patient care, making them the primary setting for guidewire and sheath usage.

Competitive Strategy & Development

Key Players: The guidewires and introducer sheaths market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic
2. Boston Scientific Corporation
3. B. Braun SE
4. Abbott
5. TERUMO CORPORATION
6. Teleflex Incorporated
7. Cordis
8. Lepu Medical Technology Beijing Co Ltd
9. ASAHI INTECC CO. LTD.
10. AngioDynamics

Trending Topics: Interventional Coronary Catheters, Coronary Stents, Peripheral Stents, PTCA Balloons, Transcatheter Heart Valves, Drug-Eluting Balloons, Bioresorbable Scaffolds, Imaging-Guided Catheters, Hydrophilic Coated Catheters, Steerable Catheters, Radial Access Catheters, Microcatheters

Global Headlines

• Boston Announces launch of Kinetix™ Guidewire – In April 2025, Boston Scientific Corporation announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures.
• Boston Announces launch of Journey™ Guidewire – In October 2025, Boston Scientific Corporation announced the global launch of its Journey™ Guidewire, an innovative 0.014" guidewire designed for use in challenging, small vessel peripheral angioplasty procedures.
• Merit Medical announced launch Prelude Wave™ Hydrophilic Sheath Introducer – In August 2025, Merit Medical Systems, Inc. announced the US commercial release of the Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Securement Technology.

Conclusion

The guidewires and introducer sheaths market for coronary and peripheral applications is positioned for sustained growth, supported by rising cardiovascular disease burden, expanding interventional procedure volumes, and continuous advancements in device design. Increasing preference for minimally invasive revascularization techniques over open surgery reinforces the need for reliable vascular access and precise navigation tools. Aging populations, lifestyle-related risk factors, and improved diagnostic rates continue to enlarge the patient pool requiring coronary and peripheral interventions. At the same time, expanding catheterization laboratory infrastructure, greater healthcare investments in emerging regions, and wider adoption of radial and peripheral access approaches strengthen market penetration. Technological enhancements such as hydrophilic coatings, better torque control, and low-profile sheath designs further improve procedural outcomes. Together, these factors establish guidewires and introducer sheaths as essential components in modern coronary and peripheral vascular care.